Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

14-fluoro-6-thiaheptadecanoic acid

Known as: FTHA 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Alterations in lipid metabolism in cancer cells impact cell structure, signaling, and energy metabolism, making lipid metabolism… Expand
2015
2015
Abnormalities in myocardial fatty acid (FA) metabolism, which are primarily driven by an increase in plasma FAs delivered to the… Expand
  • figure 1
2007
2007
BackgroundThe relationship between myocardial metabolic changes and the severity of left ventricular (LV) hypertrophy in patients… Expand
2007
2007
UNLABELLED Alterations of free fatty acid (FA) metabolism in several organs are implicated in the pathogenesis of chronic… Expand
Highly Cited
2001
Highly Cited
2001
UNLABELLED Understanding the metabolic consequences of heart failure is important in evaluating potential mechanisms for disease… Expand
Highly Cited
1999
Highly Cited
1999
Free fatty acids (FFAs) are an important substrate for myocardial and skeletal muscle metabolism, and increased availability and… Expand
Highly Cited
1998
Highly Cited
1998
UNLABELLED 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA) has been recently introduced as a new tracer for fatty acid… Expand
1996
1996
14(R,S)-[18F]-fluoro-6-thiaheptadecanoic acid (FTHA) has been proposed as a PET tracer of the beta-oxidation pathway. The aim of… Expand
1994
1994
UNLABELLED The myocardial uptake kinetics of 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA) were evaluated in humans with… Expand
Highly Cited
1991
Highly Cited
1991
14(R,S)-[18F]Fluoro-6-thia-heptadecanoic acid (FTHA) is a new radiolabeled long-chain fatty acid (LCFA) analog designed to… Expand